亚洲理论在线观看,中文字幕一区日韩精品,色一乱一伦一图一区二区精品,亚洲日本一区二区三区在线

掃碼關注公眾號           掃碼咨詢技術支持           掃碼咨詢技術服務
  
客服熱線:400-901-9800  客服QQ:4009019800  技術答疑  技術支持  質量反饋  人才招聘  關于我們  聯系我們
午夜成人理论福利片,亚洲日韩精品一区二区三区,国产色诱视频在线观看
首頁 > 產品中心 > 一抗 > 產品信息
Rabbit Anti-IGFBP1  antibody (bs-1822R)  
~~~促銷代碼KT202411~~~
訂購熱線:400-901-9800
訂購郵箱:sales@www.chomd.com.cn
訂購QQ:  400-901-9800
技術支持:techsupport@www.chomd.com.cn
說明書: 50ul  100ul  200ul
50ul/1180.00元
100ul/1980.00元
200ul/2800.00元
大包裝/詢價

產品編號 bs-1822R
英文名稱 Rabbit Anti-IGFBP1  antibody
中文名稱 胰島素樣生長因子結合蛋白1抗體
別    名 Insulin-like Growth Factor Binding Protein 1; IGFBP-1; AFBP; Alpha pregnancy associated endometrial globulin; Amniotic fluid binding protein; Binding protein 25; Binding protein 26; Binding protein 28; Growth hormone independent binding protein; hIGFBP 1; hIGFBP1; IBP 1; IBP1; IGF binding protein 1; IGF BP25; IGFBP 1; Placental protein 12; PP12.  
Specific References  (4)     |     bs-1822R has been referenced in 4 publications.
[IF=5.528] Peng Xianglan. et al. Associations between IGFBP1 gene polymorphisms and the risk of preeclampsia and fetal growth restriction. HYPERTENS RES. 2023 May;:1-15  IHC ;  Human.  
[IF=2.616] Yun-xing Fu. et al. Assessment of Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Variants in Women with Repeated Implantation Failures. Reprod Sci. 2021 Feb;28(2):406-415  IHC ;  Human.  
[IF=1.785] An J et al. A clinical and basic study of optimal endometrial preparation protocols for patients with infertility undergoing frozen?thawed embryo transfer. Exp Ther Med . 2020 Sep;20(3):2191-2199.  WB ;  Human.  
[IF=1.785] Junxia An. et al. A clinical and basic study of optimal endometrial preparation protocols for patients with infertility undergoing frozen?thawed embryo transfer. Exp Ther Med. 2020 Sep;20(3):2191-2199  WB ;  Human.  
研究領域 腫瘤  免疫學  生長因子和激素  轉錄調節因子  糖尿病  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應 Human (predicted: Mouse,Rat,Pig,Sheep,Cow,Chicken,Horse)
產品應用 WB=1:500-2000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ELISA=1:5000-10000
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理論分子量 30kDa
細胞定位 分泌型蛋白 
性    狀 Liquid
濃    度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from human IGFBP1: 150-250/259 
亞    型 IgG
純化方法 affinity purified by Protein A
緩 沖 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
產品介紹 Insulin like growth factor binding protein 1 (IGFBP1) is a member of the superfamily of insulin like growth factor (IGF) binding proteins which include six high affinity IGF binding proteins (IGFBP) and at least four low affinity binding proteins referred to as IGFBP related proteins (IGFBPrP). The IGFBP members are cysteine rich proteins with conserved cysteine residues clustered in the amino terminal and the carboxy terminal regions of the molecule. The N terminal and C terminal regions are highly homologous among rat, human and bovine sequences. Contained within IGFBP1 and 2 is an integrin receptor recognition sequence (RGD) that is responsible for promoting cell migration by an IGF independent action. IGFBPs hold a central position in IGF ligand receptor interactions through influences on both the bioavailability and distribution of IGFs in the extracellular environment. IGFBPs will either inhibit or enhance the biological activities of IGF or act in an IGF independent manner. Post translational modification of IGFBPs, including phosphorylation and proteolysis, will modify the affinities of the binding proteins for IGF and may indirectly regulate IGF actions. IGFBP1 is expressed in liver, decidua, and kidneys and is the major IGF binding protein in human amnionic fluid. In hepatocytes, IGFBP1 production is regulated at the transcriptional level due to the effects of insulin and corticosteriods. IGFBP1 is the major determinant of the level of free IGF in serum. The expression of IGFBP1 is inhibited by insulin, IGFI, and IGFII and is stimulated by glucocorticoids, thyroid hormone, and epidermal growth factor (EGF), indicating an endocrine function. IGFBP1 shows inhibitory actions on cell proliferation and differentiation, presumably by interfering with the interactions between IGF and the IGF receptor (IGFR).

Function:
IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Promotes cell migration.

Subunit:
Binds equally well IGF1 and IGF2.

Subcellular Location:
Secreted.

Post-translational modifications:
Phosphorylated; probably by casein kinase II. Alters the affinity of the protein for IGFs.

Similarity:
Contains 1 IGFBP N-terminal domain.
Contains 1 thyroglobulin type-1 domain.

SWISS:
P08833

Gene ID:
3484

Database links:

Entrez Gene: 3484 Human

Entrez Gene: 16006 Mouse

Entrez Gene: 25685 Rat

Omim: 146730 Human

SwissProt: P08833 Human

SwissProt: P47876 Mouse

SwissProt: P21743 Rat

Unigene: 642938 Human

Unigene: 21300 Mouse

Unigene: 34026 Rat



生長因子和激素( Growth Factor and Hormones)
胰島素樣生長因子結合蛋白1(IGFBP-1)是IGF/IGFBP家族中的一個重要成員,在多種疾病尤其是腫瘤中其表達明顯增高,可能通過調節胰島素樣生長因子(insulin-like growth factor,IGF)發揮作用,促進腫瘤的發生發展。
產品圖片
Sample: Lane 1: IGFBP1 fusion protein (bs-43004P) 0.2ug Primary: Anti-IGFBP1 (bs-1822R) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 30kDa Observed band size: 30kDa
Tissue/cell: musle of human endometrium; 4% Paraformaldehyde-fixed and paraffin-embedded; Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min; Incubation: Anti-IGFBP1 Polyclonal Antibody, Unconjugated(bs-1822R) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining
版權所有 2004-2026 www.www.chomd.com.cn 北京博奧森生物技術有限公司
通過國際質量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫療器械-質量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網安備110107000727號